FRANKLIN, Mass., Nov. 8 /PRNewswire-FirstCall/ -- Sontra Medical
Corporation (Nasdaq SC: SONT) announced today that it will host a conference
call and listen-only Webcast on Thursday, November 11, 2004 at 11:00 a.m. ET
to provide a business update and discuss third quarter 2004 financial results.
The conference call is open to all interested parties and will be hosted
by Thomas W. Davison PhD, President and Chief Executive Officer, and Sean
Moran, Chief Financial Officer.
To participate in the live conference call, please dial 973-409-9259.
A listen-only Webcast of the conference call will be available at
http://www.viavid.net/detailpage.aspx?sid=0000202C
About Sontra Medical Corporation (http://www.sontra.com)
Sontra Medical Corporation is a technology leader in transdermal science.
Sontra's SonoPrep ultrasound-mediated skin permeation technology combined with
technical competencies in transdermal drug formulation, delivery systems
biosensors is creating a new paradigm in transdermal drug delivery and
diagnosis. The SonoPrep technology has demonstrated strong initial human
clinical trials at leading universities and medical centers for several
billion market opportunities including that the transdermal delivery of
vaccines and large molecule drugs and continuous non-invasive glucose
monitoring. Sontra is currently marketing the SonoPrep device and procedure
tray for use with topical lidocaine to achieve rapid (within five minutes)
skin anesthesia.
SonoPrep is a registered trademark of Sontra Medical Corporation. All
other company, product or service names mentioned herein are the trademarks or
registered trademarks of their respective owners.
Contacts:
Sean Moran, CFO or Evan Smith, CFA / Erica Pettit
Sontra Medical Corporation KCSA Worldwide
Tel: 508-553-8850 Tel: 212-896-1251 / 212-896-1248
SOURCE Sontra Medical Corporation
 back to top
Related links:
http://www.sontra.com
CONTACT:
Sean Moran, CFO of Sontra Medical
Corporation, +1-508-553-8850; or Evan Smith, CFA,
+1-212-896-1251, or Erica Pettit, +1-212-896-1248, both of KCSA
Worldwide
|
